Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension.

about

Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension.

Item

http://www.wikidata.org/entity/Q41835562

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Metabolic effect of combined t ...... s with essential hypertension.

@en

type

Item

label

Metabolic effect of combined t ...... s with essential hypertension.

@en

prefLabel

Metabolic effect of combined t ...... s with essential hypertension.

@en

P1476

Metabolic effect of combined t ...... s with essential hypertension.

@en

P2093

Fumiyasu Yamasaki

http://www.w3.org/2001/XMLSchema#string

Takashi Furuno

http://www.w3.org/2001/XMLSchema#string

Takayuki Sato

http://www.w3.org/2001/XMLSchema#string

Tetsuro Sugiura

http://www.w3.org/2001/XMLSchema#string

Toru Kubo

http://www.w3.org/2001/XMLSchema#string

Yoshinori Doi

http://www.w3.org/2001/XMLSchema#string

Yuji Shimizu

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism.

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension

Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system.

Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator.

Long-acting nifedipine in the management of the hypertensive patient.

Results of the ONTARGET and TRANSCEND studies: an update and discussion.

P304

753-758

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJGM.S28890

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232226375

http://www.w3.org/2001/XMLSchema#string

P698

23049268

http://www.w3.org/2001/XMLSchema#string

P932

3459667

http://www.w3.org/2001/XMLSchema#string